| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | Bluejay Diagnostics reports Q2 results | 1 | Seeking Alpha | ||
| 13.08. | Bluejay Diagnostics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.08. | Bluejay Diagnostics completes enrollment in sepsis test study | 1 | Investing.com | ||
| BLUEJAY DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 13.08. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | 348 | GlobeNewswire (Europe) | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| 12.08. | Bluejay Diagnostics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 22.07. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.07. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | 255 | GlobeNewswire (Europe) | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| 09.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.06. | Bluejay Diagnostics closes $8.5 million private placement | 1 | Investing.com | ||
| 06.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 03.06. | What's Going On With Bluejay Diagnostics Shares On Wednesday? | 3 | Benzinga.com | ||
| 02.06. | Bluejay Diagnostics raises $8.5M in private placement | 2 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | 4 | GlobeNewswire (USA) | ||
| 02.06. | Why Is Bluejay Diagnostics Stock Soaring Tuesday? | 7 | Benzinga.com | ||
| 02.06. | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | 718 | AFX News | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics partners with Argonaut for US manufacturing | 4 | Investing.com | ||
| 02.06. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership | 236 | GlobeNewswire (Europe) | ACTON, Mass. and CARLSBAD, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company") (NASDAQ: BJDX), a medical diagnostics company focused on near-patient testing... ► Artikel lesen | |
| 02.06. | Bluejay Diagnostics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 07.05. | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Provides First Quarter 2026 Corporate Update | 210 | GlobeNewswire (Europe) | ACTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. ("Bluejay" or the "Company"), a medical diagnostics company focused on improving patient outcomes in critical care settings... ► Artikel lesen | |
| 07.05. | Bluejay Diagnostics, Inc. - 10-Q, Quarterly Report | - | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Carl Zeiss Meditec-Aktie: Ist das die Trendwende? | Die Carl Zeiss Meditec-Aktie konnte sich von ihrem Tief im März bei etwa 23 € wieder erholen und notiert am Mittwoch aktuell bei 31,60 €. Zuvor befand sich die Aktie über längere Zeit in einem Abwärtstrend.... ► Artikel lesen | |
| HIMS & HERS HEALTH | 28,540 | -1,38 % | Hims & Hers Health facing penalties from Visa for credit card disputes - report | ||
| ATOSSA THERAPEUTICS | 2,200 | +1,85 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| GE HEALTHCARE TECHNOLOGIES | 63,95 | -0,19 % | GE HealthCare Technologies Names William Grogan CFO | WASHINGTON (dpa-AFX) - Tuesday, GE HealthCare Technologies Inc. (GEHC) announced the appointment of William Grogan as Chief Financial Officer, effective September 14, 2026.Following the appointment... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,510 | -1,40 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| BUTTERFLY NETWORK | 8,146 | -0,33 % | Michael Burry sagt nur: wow: Butterfly +56 %: Die kleine Aktie hinter Midjourneys 60-Sekunden-Körperscanner | © Foto: Jaque Silva - NurPhotoMidjourney plant einen 60-Sekunden-Körperscanner per Ultraschall und KI. Butterfly liefert die Technik für den Prototyp. Anleger haben die Aktie am Donnerstag brutal hochgekauft... ► Artikel lesen | |
| BEYOND AIR | 5,040 | 0,00 % | Beyond Air, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 2,720 | -0,37 % | Aethlon Medical auf Emerging Growth Conference: Frühe Krebssignale und nächste Schritte | ||
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| ANGIODYNAMICS | 13,400 | -0,74 % | AngioDynamics auf Canaccord Genuity Konferenz: Strategiewechsel zu MedTech-Wachstum wird vertieft | ||
| APYX MEDICAL | 2,520 | 0,00 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,975 | -0,06 % | Anteris Technologies Global Corp.: Anteris Technologies Announces Results for the Second Quarter of 2026 | MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) a global healthcare company committed... ► Artikel lesen | |
| ADAPTHEALTH | 5,635 | +0,09 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 5,270 | 0,00 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PICARD MEDICAL | 3,220 | 0,00 % | Picard Medical, Inc.: Picard Medical Reports Second Quarter 2026 Financial Results | - Revenue Increases 39% and Net Loss Decreases 16%- Year-to-Date Revenue Increases 50%, with ~$0.9 Million in Gross Profit TUCSON, Ariz., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE... ► Artikel lesen |